BDNF rs6265 Variant Alters Outcomes with Levodopa in Early-Stage Parkinson’s Disease

Disease outcomes are heterogeneous in Parkinson’s disease and may be predicted by gene variants. This study investigated if the BDNF rs6265 single nucleotide polymorphism (SNP) is associated with differential outcomes with specific pharmacotherapy treatment strategies in the “NIH Exploratory Trials...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neurotherapeutics
Main Authors: Fischer, D. Luke, Auinger, Peggy, Goudreau, John L., Cole-Strauss, Allyson, Kieburtz, Karl, Elm, Jordan J., Hacker, Mallory L., Charles, P. David, Lipton, Jack W., Pickut, Barbara A., Sortwell, Caryl E.
Formato: Artigo
Idioma:Inglês
Publicado: Springer International Publishing 2020
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7851242/
https://ncbi.nlm.nih.gov/pubmed/33215284
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13311-020-00965-9
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares